What Is Restrictive Cardiomyopathy?

doctor and patient

Jochen Tack / Getty Images

Table of Contents
View All
Table of Contents

Restrictive cardiomyopathy (RCM) is a heart condition in which the walls of the heart become rigid and cannot expand normally to fill with blood. Although it rarely produces noticeable symptoms, RCM can cause heart failure and must be monitored closely once it's diagnosed. Restrictive cardiomyopathy is the rarest form of cardiomyopathy (an umbrella term for any disease of the heart muscle), comprising fewer than 5% of all cardiomyopathies and affecting mostly older people. Treatment for restrictive cardiomyopathy can range from taking medication to receiving a heart transplant.

Also Known As

  • Idiopathic restrictive cardiomyopathy
  • Infiltrative cardiomyopathy

Types of Restrictive Cardiomyopathy

Restrictive cardiomyopathy develops as a result of scar tissue or other abnormal tissue replacing healthy tissue, causing the ventricles of the heart to become stiff and unyielding to blood flow.

There are two classifications of restrictive cardiomyopathy: primary and secondary. Primary RCM refers to conditions in which the disease develops independently of underlying factors. Examples of restrictive cardiomyopathy in this category include:

  • Endomyocardial fibrosis
  • Löffler's endocarditis
  • Idiopathic restrictive cardiomyopathy

Secondary RCM occurs as a result of another disease that interferes with the normal function of the heart muscle, reducing its elasticity and restricting the ability of the ventricles to fill with blood. There are two categories of such diseases:


Restrictive cardiomyopathy causes relatively few symptoms, if any. Those that do occur resemble classic symptoms of heart failure: 

  • Dyspnea (shortness of breath)
  • Edema (swelling of the legs and feet)
  • Weakness
  • Fatigue
  • Inability to exercise
  • Heart palpitations
  • Weight gain and bloating
  • Nausea
  • Poor appetite

Less common symptoms of restrictive cardiomyopathy include:

  • Fainting, often caused by irregular heart rhythms or abnormal blood vessel performance during physical exertion
  • Chest pain or pressure, which mainly occurs with activity, but can also happen at rest or after eating

Severe restrictive cardiomyopathy can cause abdominal organ congestion, producing an enlarged liver and spleen, and ascites (fluid accumulation in the abdominal cavity).


Restrictive cardiomyopathy occurs when the heart muscle becomes stiff, preventing it from fully relaxing during the diastolic phase of the cardiac cycle—the period between heartbeats when the heart must expand to fill with blood. This makes it difficult for the ventricles of the heart to fill adequately and causes the atria to enlarge because they must work harder than normal. The size and systolic function of the ventricles usually remain normal or near-normal, at least until later stages of the disease.

What causes the heart muscle to become stiff is not fully understood. The condition is not related to coronary artery disease (CAD), but a number of conditions are associated with RCM, including:

  • Sarcoidosis, a rare condition in which groups of immune cells form lumps, called granulomas, in organs in the body. It most often affects the lungs and lymph nodes in the chest, but can directly impact the heart.
  • Hemochromatosis, a disease characterized by the accumulation of excess iron in the body. Unneeded iron is toxic and can cause organ damage.
  • Amyloidosis, in which abnormal proteins build up in the body's organs, including the heart.
  • Connective tissue disorders, such as scleroderma
  • Certain cancer treatments, including radiation and chemotherapy
  • Storage diseases, such as Gaucher disease


Your healthcare provider can detect restrictive cardiomyopathy with a physical exam, medical history, and diagnostic tests. Echocardiogram is the standard test used to confirm RCM. It shows diastolic abnormalities and evidence of blood not filling the ventricles properly.

Other tests that may be used to diagnose and evaluate restrictive cardiomyopathy include:

In rare cases, a healthcare provider will order a heart muscle biopsy, which can help make the diagnosis when an infiltrative disease (such as sarcoidosis) or storage disease is present.

Differential Diagnosis

Restrictive cardiomyopathy may be confused with constrictive pericarditis, in which the layers of the pericardium (the membrane encasing the heart) become thickened, calcified, and rigid. Your healthcare provider may need to rule this out in order to confirm a restrictive cardiomyopathy diagnosis.


Treatment for restrictive cardiomyopathy involves managing heart failure as well as addressing underlying causes. Unfortunately, there is no specific treatment that directly reverses the RCM itself.

There are, however, an array of treatment options that can help.

Lifestyle Changes

Your healthcare provider will likely recommend diet and exercise as a part of your treatment plan. Exercise can help you lose weight and strengthen your heart. Adopting a low-sodium diet and losing weight help lower blood pressure, which eases the strain on your heart.


Diuretics, such as Lasix (furosemide), offer the most benefit for treating restrictive cardiomyopathy by reducing edema (swelling) but must be used judiciously and their effect monitored, as they can work too well, depleting the body of more fluid than is healthy. This may further reduce the amount of blood that fills the ventricles during the diastolic phase of each heart beat.

Close monitoring of diuretic use involves measuring weight at least daily and periodically checking blood to look for signs of chronic dehydration. The optimal dose of diuretics may change over time.

Calcium Channel Blockers

Calcium channel blockers can help RCM by directly improving the diastolic function of the heart and slowing the heart rate to allow more time to fill the ventricles between heartbeats. For similar reasons, beta-blockers can also be helpful. If atrial fibrillation is present, it is critical to control the heart rate to allow adequate time to fill the ventricles. The use of calcium channel blockers and beta-blockers can usually accomplish this goal.

Ace Inhibitors

There is some evidence that ACE inhibitors may benefit at least some people with restrictive cardiomyopathy, possibly by reducing heart muscle stiffness.

Heart Transplant

Your healthcare provider may recommend a heart transplant as a surgical option if other treatments fail to control restrictive cardiomyopathy symptoms.

A Word From Verywell

Restrictive cardiomyopathy is rare, but if you develop this condition you likely won't have symptoms and your quality of life will not be affected. If you are diagnosed with restrictive cardiomyopathy, your prognosis should be good: In a 2012 study, the one-, five-, and 10-year survival rates for RCM patients overall was 88%, 66%, and 45%, respectively. What's more, despite being a rare type of cardiomyopathy, there are numerous effective treatment options that your healthcare provider can finetune specifically for you.

7 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Muchtar E, Blauwet L, Gertz M. Restrictive cardiomyopathy: Genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ. Res. 2017;121:819–837. doi:10.1161/CIRCRESAHA.117.310982

  2. American Heart Association. Restrictive cardiomyopathy.

  3. Bott-Silverman C, Baran A. Dilated and restrictive cardiomyopathies. Cleveland Clinic.

  4. Cleveland Clinic. Restrictive cardiomyopathy.

  5. Muchtar E, Blauwet LA, Gertz MA. Restrictive cardiomyopathyCirc Res. 2017;121(7):819-837. doi:10.1161/circresaha.117.310982

  6. Cleveland Clinic. Restrictive cardiomyopathy: Diagnosis and tests.

  7. DePasquale E, Nasir K, Jacoby D. Outcomes of adults with restrictive cardiomyopathy after heart transplantation. J. Heart Lung Transplant. 2012;31(12):1269-1275. doi:2012;31(12):1269-1275